Edge Therapeutics, Inc. and PDS Biotechnology Corporation announced that their respective boards of directors have approved a definitive merger agreement.
Moderna will be getting all the headlines for its monster $500 million IPO attempt this week, but that shouldn’t overshadow the major $100 million IPO that early-stage Synthorx has just announced, and what this says about the biotech market.